• Support
  • Client Login
  • Learn More
  • Solutions
    • Prognos Oncology
    • Prognos Rare Disease
    • Commercial Analytics
    • Precision Marketing
  • About
    • Team
    • Become a Data Provider
    • Careers
    • News
    • Resources
  • Insights
    • Case Studies
      • LEMS
      • Lupus Nephritis
      • NSCLC
      • Oncology
      • Rare Disease
    • Webinar Series
  • Contact Us
Home Insights Lab Testing Trends Year-to-Date Through May 22

Lab Testing Trends Year-to-Date Through May 22

  • May 28, 2020
  • Posted in Lab Testing Trends
Lab Testing Trends Year-to-Date Through May 22

Prognos is analyzing lab testing trends in 2020 and more specifically, looking at the impact of COVID-19 on testing trends at a national level.

For more information on the regional and local level, or a specific test or brand contact us.

Methodology: A large representative sample from the Prognos lab testing registry was pulled as a proxy for a national volume of testing. Then trends are compared on a weekly basis year-to-date.

Summary Findings

Week ending May 22nd, 2020

  • For 2020, the national trend in testing was initially stable through the week ending 3/13/20.  
  • There were expected drops in January and February due to holidays (MLK/President’s Day).
  • Over the two-week period ending 3/27, the national trend decreased 24% and 40% weekly, for an overall drop of 54% over those two weeks.
  • Since then, the market trend has stabilized and showing signs of recovery with consecutive weeks of double-digit percentage increases. Data from the most recent period (week ending 5/22) shows an increase of 13% over the prior week.
  • As of the week ending 5/22, the market has rebounded to within 15% of the weekly volume immediately prior to the slide in mid-March.
  • In comparing the most recent week’s volume to same week in the previous year, the trend shows an improvement as well, with the week ending 5/22/20 only 11% lower than the same week in 2019.  

For the most recent period (week ending 5/22) testing trends showed a 13% increase over the prior week, indicating a clear upward trend in testing.

The national trend over the most recent annual period (4/19 – 5/20) shows a stable weekly trend, with dips associated with holidays.  Testing for the week of 5/22/20 is 13% higher than prior week, and only 11% lower than same week prior year, which is also an improvement over last week’s comparison where testing was 20% lower than the same week prior year.

For more information on the regional and local level, or a specific test or brand, contact us.

« Lab Testing Trends Year-to-Date Through May 15
How Prognos is Using COVID-19 Data »

    Categories

    • AI (7)
    • Alerts (8)
    • artificial intelligence (1)
    • Blood Cancer (1)
    • Blood Cancer Awareness Month (1)
    • Breast Cancer (1)
    • Clinical (1)
    • Commercial Launch Excellence (8)
    • Compliance (1)
    • Conference (3)
    • diabetes (1)
    • diagnosis (1)
    • digital (1)
    • Disease Awareness (14)
    • Genomics Data (2)
    • HbA1c (1)
    • HCP omnichannel marketing (2)
    • healthcare AI (1)
    • IHC (1)
    • ISPOR (1)
    • Lab Testing Insights (27)
    • Lab Testing Trends (15)
    • Liquid Biopsy (1)
    • Marketplace (8)
    • NSCLC (1)
    • Omnichannel Marketing (8)
    • Oncology (3)
    • Patient Journey (7)
    • Rare Disease (3)
    • Reuters Pharma (1)
    • RWD Marketplace (3)
    • Sponsored Testing (1)
    see all topics
    • Products
      • Commercial Analytics
      • Oncology
      • Rare Disease
      • Precision Marketing
    • Company
      • Insights
      • Careers
      • News
    • Prognos Marketplace
      • Prognos Factor
    • Contact Us
    • Terms of Use
    • Privacy Policy
    • Site Map
    © Prognos Health, 2022. All Rights Reserved.